Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medicines Australia Says Pharmaceutical Benefits Scheme Spending Sustainable

This article was originally published in PharmAsia News

Executive Summary

PERTH, Australia - A new report by Access Economics says that spending on Australia's Pharmaceutical Benefits Scheme will not spiral out of control as previously predicted by the Liberal Howard government, Medicines Australia announced April 3
Advertisement

Related Content

Australian Labor Government Slashes Drug Prices For Big Pharma, Delivers Tax Credits To Struggling Biotechs In 2009 Budget
Australian Labor Government Slashes Drug Prices For Big Pharma, Delivers Tax Credits To Struggling Biotechs In 2009 Budget
Australian Labor Government Slashes Drug Prices For Big Pharma, Delivers Tax Credits To Struggling Biotech In 2009 Budget
Australian Labor Government Slashes Drug Prices For Big Pharma, Delivers Tax Credits To Struggling Biotech In 2009 Budget
Australia Department Of Innovation Releases 10-Year Plan On Pharma Strategy
Australia Department Of Innovation Releases 10-Year Plan On Pharma Strategy
Advertisement
UsernamePublicRestriction

Register

SC071532

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel